Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC16A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CBX5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM72A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FAM216A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POU3F2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BNIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CENPV - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPAT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BIRC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLTF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPT11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEIOC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REEP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBL1XR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHFR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B4GALT6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMTM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on